Abstract
Helicobacter pylori was examined in 110 patients (82 (74.5) with gastritis, 18 (16.4) with duodenitis, six (5.5) with duodenal ulcer and gastroesophageal reflux, and four (3.6 %) with normal) with gastrointestinal problems living in rural area, no history of macrolide use, and detected by culture (71.8) or direct detection from gastric biopsies by PCR (82.7 %). Also, cagA gene was identified using PCR and was found positive in 68/91 (74.7 %) strains. The prevalence of clarithromycin-resistant H. pylori was investigated by two methods including PCR–RFLP (7.7 (A2142G 1.1 and A2143G 6.6 %)) and twofold agar dilution (8.9 %) to detect phenotypic and genotypic status simultaneously. Among all the H. pylori positive patients, eight (8.8 %) isolates were found to be resistant to clarithromycin by at least one of the AD and/or PCR–RFLP methods. H. pylori positive rates were significantly correlated with patients' sex, age, and endoscopic findings (p = 0.040, <0.001 and <0.001, respectively). There were no differences in gender or endoscopic findings related to cagA + and cagA − patients. The gene of cagA was not significantly helpful in predicting the clinical outcome of H. pylori infection alone. In conclusion, we revealed that there was a low prevalence of primer clarithromycin resistance in patients living in rural area with no history of macrolide use. The prevalence of mutant strains among the macrolide-resistant H. pylori varies even geographically between close provinces.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Gastroenterological Association (1998) American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 114:579–581
Baglan PH, Bozdayi G, Ozkan M, Ahmed K, Bozdayi AM, Ozden A (2006) Clarithromycin resistance prevalence and iceA gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol 44:409–416
Chomvarin C, Namwat W, Chaicumpar K et al (2008) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 12:30–36
Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement, M100-S20. CLSI, Wayne, p 107
De Francesco V, Giorgio F, Hassan C et al (2010) Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver Dis 19:409–414
DeFrancesco V, Giorgio F, Ierardi E et al (2011) Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J Gastrointestin Liver Dis 20:235–239
Erzin Y, Koksal V, Altun S et al (2006) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 11:574–580
Fluit AC, Visser MR, Schmitz FJ (2001) Molecular detection of antimicrobial resistance. Clin Microbiol Rev 14:836–871
Hybenova M, Hrda P, Potuznikova B, Pavlik E, Stejskal V, Dosedel J, Sterzl I (2010) Lymphocyte proliferative response to Helicobacter pylori antigens in H. pylori-infected patients. Folia Microbiol 55:649–656
Kaya AD, Öztürk CE, Akcan Y et al (2007) Prevalence of Helicobacter pylori in symptomatic patients and detection of clarithromycin resistance using melting curve analysis. Curr Ther Res 68:151–160
Lima VP, Silva-Fernandes IJ, Alves MK, Rabenhorst SH (2011) Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: an association with histopathological parameters. Cancer Epidemiol 35:e32–e37
Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M (1998) Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43:317–321
Malfertheiner P, Megraud F, O’Morain C, The European Helicobacter Study Group (EHSG) et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781
Matsunari O, Shiota S, Suzuki R et al (2012) Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol 50:876–883
Mishra S, Singh V, Rao GRK, Dixit VK, Gulati AK, Nath G (2008) Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol 8:815–819
Nagiyev T, Yula E, Abayli B, Koksal F (2009) Prevalence and genotypes of Helicobacter pylori in the gastric piopsy specimens from patients with gastroduodenal pathologies in Cukurova Region of Turkey. J Clin Microbiol 47:4150–4153
Nagiyev T, Köksal F, Abaylı B, Yula E (2010) Comparison of culture and GlmM-PCR methods for detecting Helicobacter pylori in antral and corpus biopsy specimens in patients with gastroduodenal disorders. Turk Klinikleri J Med Sci 30:919–924
Onder G, Aydin A, Akarca U, Tekin F, Ozutemiz O, Ilter T (2007) High Helicobacter pylori resistance rate to clarithromycin in Turkey. J Clin Gastroenterol 41:747–750
Owen RJ (2002) Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50:285–289
Saribasak H, Salih BA, Yamaoka Y, Sander E (2004) Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol 42:1648–1651
Satomi S, Yamakawa A, Matsunaga S et al (2006) Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol 41:668–673
Sezgin O, Aslan G, Altıntaş E, Tezcan S, Serin MS, Emekdaş G (2008) Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol 19:163–167
Versalovic J, Shortridge D, Kibler K et al (1996) Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 40:477–480
Wong WM, Gu Q, Wang WH et al (2003) Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance. Clin Infect Dis 37:882–889
Xia Y, Yamaoka Y, Zhu Q, Matha I, Gao X (2009) A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One 4:e7736
Yucel T, Aygin D, Sen S, Yucel O (2008) The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 61:179–183
Yula E, Nağıyev T, Köksal F (2010) Comparison of two different primer sets used for detection of Helicobacter pylori DNA by polymerase chain reaction assay in gastric tissues. Turk Klinikleri J Med Sci 30:1166–1170
Conflict of interest
The authors have not declared any conflicts of interest.
Ethical standards
The experiments comply with the current laws of the Republic of Turkey.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yula, E., Nagiyev, T., Kaya, Ö.A. et al. Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA + status and clinical outcome. Folia Microbiol 58, 141–146 (2013). https://doi.org/10.1007/s12223-012-0192-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-012-0192-8